Roger Kitterman, MBA is Vice President, Venture and Managing Partner of the Partners Innovation Fund. In this role, he leads the Innovation Fund and Licensing teams. Roger also serves as Executive Director of the Boston Biomedical Innovation Center, an NHLBI funded program to develop technologies in the areas of heart, lung, blood, and sleep.
Roger has been with the Partners Innovation Fund, a $140 million fund investing in Partners spinouts, since its launch in 2008. He is an experienced venture capital investor with more than 20 years in the industry and has guided multiple venture-backed companies through the earliest stages of development. He has also been the startup CEO for three venture-backed companies and is a founder of Mass Medical Angels. He has previously served as a partner at life science-focused venture funds in the Boston area. Roger began his venture capital career in Eastern Europe with the Bulgarian- American Enterprise Fund, a $55 million venture capital fund. Roger holds an MBA in Finance and Business Development from the Columbia Business School and an AB from Harvard College. Representative investments include Adheron Therapeutics, CoStim Pharmaceuticals, Daktari Diagnostics, Provasculon, and RaNA Therapeutics.